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Figure 1. Iron-containing moieties in proteins.
(A) Iron–sulfur clusters within proteins can take several different forms with variations in the 
number of iron and sulfur atoms. 2Fe–2S and 4Fe–4S clusters bridged by cysteines are shown 
as examples. (B) Iron inserted into the porphyrin ring forms heme. (C) The oxo di-iron moi-
ety from ribonucleotide reductase is shown (modified from Stubbe and Riggs-Gelasco (1998), 
Trends Biochem. Sci. 23, 438–443). The essential nature 
of iron usage and 
regulation
Jerry Kaplan and Diane M. Ward
The facile ability of iron to gain 
and lose electrons has made iron 
an important participant in a wide 
variety of biochemical reactions. 
Binding of ligands to iron modifies its 
redox potential, thereby permitting 
iron to transfer electrons with 
greater or lesser facility. The ability 
to transfer electrons, coupled with 
its abundance, as iron is the fourth 
most abundant mineral in the earth’s 
crust, have contributed to iron being 
an element required by almost all 
species in the six kingdoms of life. 
Iron became an essential element for 
both Eubacteria and Archeabacteria 
in the early oxygen-free stages of the 
earth’s evolution. With the advent of 
an oxygen-rich environment, the redox 
properties of iron made it extremely 
useful, as much of iron utilization in 
eukaryotes is focused on oxygen 
metabolism, either as an oxygen 
carrier or as an electron carrier that 
can facilitate oxygen-based chemistry. 
Three major classes of iron-
containing proteins carry out these 
reactions: iron–sulfur cluster-
containing proteins; heme-containing 
proteins; and iron-containing enzymes 
that are devoid of iron–sulfur clusters 
or heme. Examples of iron-containing 
moieties in these proteins are shown in 
Figure 1. Iron–sulfur (Fe–S)-containing 
proteins are found as independent 
enzymes that catalyze discrete 
chemical reactions or as components 
in complexes that transport electrons. 
Proteins that bind heme — a complex 
of iron and protoporphyrin — play a 
major role in oxygen binding and in 
the metabolism of oxygen-containing 
molecules. Finally, iron can bind to 
proteins independently of Fe–S or 
heme and those proteins play a major 
role in diverse metabolic activities. 
For example, oxo di-iron (Fe–O–Fe) 
enzymes are widely used for 
dehydrogenation reactions that utilize 
molecular oxygen to introduce double 
bonds. The di-iron center is found in a 
variety of proteins, including methane 
Primer monooxygenase, ribonucleotide reductase, and methyl sterol oxidase. 
The three types of iron-containing 
protein are found in all biological 
kingdoms, although depending on the 
oxygen tension of the environment, 
heme and oxo di-iron-containing 
enzymes, which are heavily used 
in oxygen-based metabolism, may 
be absent. For example, aerobically 
growing yeast express all three types 
of iron-containing proteins, while 
anaerobically growing yeast only 
express iron–sulfur cluster-containing 
proteins.
Mechanisms of iron acquisition
The advent of an oxygenated 
environment rendered iron acquisition 
problematic. Ferrous iron (Fe2+) is 
reasonably soluble at neutral pH 
in anoxic environments, but in the 
presence of oxygen aqueous Fe2+ 
is rapidly converted to the relatively 
insoluble ferric (Fe3+) oxide-hydroxide. 
Fe3+ is almost insoluble at neutral 
pH (10–18 M) but can be solubilized 
by acidification (10–6M at pH 3.0). 
Two biochemical approaches 
evolved to permit organisms to 
acquire iron. Organisms may acidify 
their immediate environment to 
facilitate the solubilization of Fe3+, 
followed by reduction of Fe3+ to Fe2+ 
(Figure 2A). Reduction requires the 
transmembrane transfer of electrons 
by transmembrane proteins from 
cytosolic nicotinamide adenine 
dinucleotide phosphate (NADPH) to 
extracellular acceptors, such as Fe3+ 
complexes. Such transmembrane reductases are found in all eukaryotes 
(Fre1 in Saccharomyces cerevisiae, 
FRO1 in Arabidopsis thaliana and 
Steap1 in vertebrates). Fe2+ is then 
transported across the plasma 
membrane. A number of different 
transporters have evolved to mediate 
such transport, one of which (NRAMP/
SMF/DMT) has been conserved 
throughout evolution and is found in 
species belonging to all kingdoms. 
This transporter is a H+/metal 
symporter that takes advantage of a 
low pH to drive the transmembrane 
import of iron. This transporter 
is responsible for iron uptake 
from the lumen of the vertebrate 
intestine as well as the lumen of 
intracellular endosomes. In addition 
to the NRAMP/DMT/SMF family of 
transporters, other Fe2+ transporters 
exist which are more species 
specific, such as IRT1 in plants and 
Fet4 in Saccharomyces. All of these 
transporters can utilize Fe2+ as a 
substrate but they are not specific 
for Fe2+ and can accumulate other 
transition metals, most commonly 
Mn2+ and to a lesser extent Zn2+ and 
Cu1+. 
The second approach taken by 
organisms to acquire iron is to 
synthesize and secrete small organic 
molecules termed siderophores, which 
have a high affinity for Fe3+ (Figure 
2B). The affinity of deferoxamine, a 
siderophore produced by the bacteria 
Streptomyces pilosus, is reported 
to be (Kd) 10–33 M. This affinity is 
high enough to bind the sparingly 
soluble Fe3+ at neutral pH. Specific 
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Figure 2. Iron acquisition mechanisms.
(A) An acidic extracellular environment helps maintain the solubility of Fe3+. A reductase on 
the cell surface reduces Fe3+ to Fe2+. Fe2+ is transported into the cytoplasm by cell surface 
transporters, an example of which is the divalent metal transporter (DMT1). (B) Organisms 
secrete small organic molecules termed siderophores that bind soluble Fe3+ with high affin-
ity. The Fe3+-containing siderophore binds to a siderophore transporter, which transports the 
Fe–siderophore complex into the cytoplasm. PM, plasma membrane.cell-surface transporters accumulate 
Fe3+–siderophore complexes. There 
is a wide variety of siderophores 
produced by organisms and a given 
organism may produce more than one 
type of siderophore. For example, 
Escherichia coli can produce four 
different types of siderophore. Both 
plants (grasses) and fungi are also 
capable of producing siderophores 
and express specific siderophore 
transporters. Even organisms 
such as S. cerevisiae that do not 
produce siderophores may express 
siderophore transporters. 
Regulation of iron acquisition 
and utilization
The same properties of electron 
transfer that make iron so useful in 
biochemical reactions can result 
in the generation of toxic oxygen 
radicals. Thus, the concentration 
of iron in biological fluids is tightly 
regulated. This regulation is achieved 
through the coordinated activities 
of elemental iron transporters, 
siderophore biosynthetic enzymes 
and siderophore transporters. The 
expression of genes and proteins 
involved in iron acquisition and 
storage is regulated by mechanisms 
extending from transcription to 
post-translational modifications. 
Transcription of iron-acquisition 
systems is regulated by iron 
availability; transcription is increased 
by iron scarcity and decreased by 
iron surplus. Two major metal-sensing 
transcription factors in bacteria, Fur 
and Dtx, are primarily transcriptional 
repressors. The Fur protein binds iron 
and, to a lesser degree, Mn2+ and 
controls the activity of a wide variety 
of operons by occupying promoters 
when the protein is metal replete 
and dissociating from the promoters 
under conditions of metal deprivation. 
Binding of metalated Fur to specific 
DNA sequences in promoters renders 
these promoters inaccessible to RNA 
polymerase. There are, however, 
promoters that are transcriptionally 
activated by metalated Fur. 
In most fungi, a repressor 
likewise mediates transcriptional 
regulation of genes involved in iron 
acquisition. This repressor (Fep1 in 
Schizosaccharomyces pombe, Sre 
in Aspergillus nidans) is a member of 
the family of DNA-binding proteins 
that recognize GATA as part of their 
DNA-binding sequence. Under 
conditions of iron sufficiency, these proteins bind to target sequences, 
resulting in transcriptional 
repression. Iron scarcity induces the 
dissociation of the repressor from 
promoters permitting transcription. 
Transcription of iron-acquisition 
genes in S. cerevisiae and related 
yeast is controlled by two paralogous 
transcription activators Aft1 and 
Aft2. From available data, it has 
been suggested that both fungal 
transcription activators and 
repressors may not sense iron 
directly but rather sense Fe–S 
clusters. Defects in Fe–S cluster 
synthesis result in induction of the 
iron regulon independent of the 
concentration of cytosolic iron. 
Transcription of many genes 
involved in iron utilization is co-
regulated with genes required 
for oxygen metabolism. The key 
regulators of the response to hypoxia 
in vertebrates are cytosolic proteins 
termed hypoxia inducible factors 
(HIFs). These proteins (HIF1 and 
HIF2) are synthesized in the cytosol 
where they are substrates for prolyl 
hydroxylases, which are Fe2+-
containing enzymes. Hydroxylation 
requires a mitochondrially produced 
substrate, oxo-glutarate, and oxygen. 
Prolyl hydroxylation of HIF results in 
its recognition by ubiquitin ligases 
leading to HIF ubiquitination and 
degradation by the proteosome. 
Decreased oxygen tension or iron 
scarcity inhibits prolyl hydroxylation, 
resulting in the accumulation of 
HIF1/HIF2. Accumulated HIF1/HIF2 is then a component of a transcription 
factor that regulates genes involved 
in iron acquisition, energy metabolism 
and oxygen transport. For example, 
HIF1 promotes the production 
of erythropoietin, increasing the 
production of red blood cells, which 
are the greatest ‘consumers’ of iron. 
The coordinated expression of 
genes involved in iron utilization with 
genes involved in iron acquisition is 
a common theme for all organisms. 
The same transcription factors (or 
post-transcriptional regulators) that 
regulate the acquisition of iron also 
regulate changes in iron utilization. 
Under conditions of iron scarcity, 
metabolic reactions are rearranged to 
be iron sparing. For example, during 
iron scarcity E. coli stops transcription 
of iron-superoxide dismutase in favor 
of manganese-containing superoxide 
dismutase. Similarly, under iron-
limiting conditions S. cerevisiae 
decreases respiratory metabolism, 
which utilizes heme and iron–sulfur 
cluster-containing proteins, in favor 
of fermentative metabolism, which 
utilizes fewer iron-containing proteins. 
Regulation of iron storage
Invariably, changes in iron acquisition 
are accompanied by changes in iron 
storage; increased acquisition is 
coupled to decreased storage and 
vice versa. Organisms use either 
of two strategies to store iron. The 
first strategy is to bind iron in a form 
that prevents it from participating 
in biochemical reactions. Bacteria, 
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Figure 3. Post-transcriptional regulation of the expression of proteins required for iron acqisition and storage.
Many mRNAs encoding proteins involved in iron metabolism contain iron regulatory elements (IREs) in their 5’ or 3’ UTRs. When cytosolic iron 
is low, iron regulatory proteins (IRPs) bind to the 5’ IRE thereby preventing translation (in the case of ferritin or Fpn1) or to the 3’ IRE thereby 
stabilizing mRNA (as seen for TfR1 or DMT1). When cytosolic iron is high, IRPs are inactive and no longer bind IREs, allowing for either trans-
lation (ferritin or Fpn1) or mRNA degradation (TfR or DMT1). invertebrates and vertebrates 
synthesize proteins termed ferritins, 
which bind Fe2+ and oxidize it to 
Fe3+, in combination with oxygen and 
phosphate. The stored ferric iron is 
essentially unreactive and will not 
participate in oxidation–reduction 
reactions. Mammalian ferritins 
have an extraordinary capacity to 
store iron. Twelve ferritin monomers 
assemble to form a shell that can 
store up to 4,500 iron atoms. Iron can 
be recovered from ferritin for cellular 
use, although that mechanism is not 
well defined.
Plants and fungi do not express 
cytosolic ferritin; rather they store 
iron in the vacuole, which is a 
lysosome-like organelle (although 
plants do contain ferritin in plastids 
such as chloroplasts). In yeast and 
plants a homologous transporter (Ccc1 and VIT1, respectively) 
mediates entry of iron into vacuoles. 
In S. cerevisiae the iron-responsive 
transcriptional activator Yap5 
regulates CCC1 expression. Iron 
storage is coordinated with iron 
acquisition because Fe–S clusters 
also regulate Yap5 transcription. 
The absence of Fe–S clusters 
induces the low-iron transcriptional 
response and prevents the high-iron 
transcriptional response. Iron can 
be transported from the vacuole to 
the cytosol by transporters that are 
homologues of cell-surface elemental 
iron transporters. In yeast these 
transporters are regulated by the 
same transcription factors as the cell-
surface transporters. This regulation 
is designed to increase cytosolic iron 
by acquiring iron from either internal 
stores or the external environment. Vertebrates also coordinate iron 
acquisition with iron storage. The 
best-defined mechanism is through 
post-transcriptional regulation. Many 
of the mRNAs that encode proteins 
required for iron acquisition and 
storage contain stem-loop structures, 
termed iron regulated elements (IREs), 
in either the 5’ or 3’ untranslated 
regions. These regions are capable 
of binding specific proteins termed 
iron-regulated proteins (IRPs) 1 or 
2. Binding of IRPs to the IRE is iron 
sensitive and the proteins bind to 
the IRE under low cytosolic iron 
conditions. Binding of IRPs to mRNA 
containing 3’ IREs protects mRNA 
from degradation, while binding of 
IRPs to 5’ IRE-containing mRNA 
prevents translation (Figure 3). 
Following depletion of cytosolic iron, 
the translation of the 5’ IRE-containing 
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Figure 4. Vertebrate systemic iron homeostasis.
Total body iron in humans is about 3–4 g: 1–2 mg/day of iron is absorbed in the duodenum. Iron is 
then transported into plasma where it is bound to transferrin (Tf). Tf–Fe is delivered to developing 
tissues and erythrocytes. Aged erythrocytes are phagocytosed by macrophages, hemoglobin 
broken down, and iron (20–30 mg/day) transported back to plasma. When the amount of iron 
exceeds Tf-binding capacity, iron is deposited in parenchymal tissues (e.g. liver).mRNA for the iron storage protein 
ferritin or the iron exporter ferroportin 
is prevented. At the same time 
translation of the 3’ IRE-containing 
mRNAs encoding the iron transporter 
divalent metal transporter 1 (DMT1) 
and transferrin receptor 1 (TfR1) is 
not affected, permitting cellular iron 
accumulation. When cytosolic iron 
concentrations increase, the IRPs 
are released from the IREs, so that 
translation of mRNAs that mediate 
iron storage or export is increased, 
while translation of mRNAs that 
effect iron acquisition is reduced 
due to increased mRNA turnover. 
The IRPs are regulated differently 
by iron. In iron-deficient conditions 
IRP1 is an RNA-binding molecule 
but under iron sufficiency IRP1 gains 
a 4Fe–4S cluster and becomes an 
active aconitase. The presence of 
the 4Fe–4S cluster prevents IRP1 
from binding to mRNA. IRP2, on the 
other hand, is degraded under high 
iron conditions through ubiquitin-
mediated proteosomal degradation. 
The turnover of the ubiquitin ligase 
responsible for IRP2 ubiquitination is 
itself regulated by iron, such that iron 
promotes accumulation of the ligase, 
thus leading to the ubiquitination and 
degradation of IRP2. 
Mechanism and regulation of iron 
transport into organelles
Mitochondria are the site of 
synthesis for heme and Fe-S 
clusters, which are not only used 
in mitochondria but are exported 
to the cytosol and to other 
subcellular organelles. Iron entry 
into mitochondria is mediated by 
transporters that belong to the 
large family of mitochondrial carrier 
facilitators. These transporters have 
six transmembrane domains, are 
located in the inner mitochondrial 
membrane and are primarily anion 
antiporters. Two homologous 
transporters, Mrs3 and Mrs4, 
mediate iron transport in  
S. cerevisiae, and highly homologous 
proteins termed mitoferrins mediate 
mitochondrial iron transport 
in plants, invertebrates and 
vertebrates. Yeast and vertebrates 
contain two mitoferrins, although 
other species such as Oryza (rice) 
and Drosophila have only one. 
In vertebrates Mitoferrin1 and 
Mitoferrin2 are regulated differently. 
Mitoferrin1 is highly expressed 
in developing red blood cells, a cell which is specialized for heme 
synthesis, while Mitoferrin2 seems 
to be ubiquitously expressed. The 
increased expression of Mitoferrin1 
in developing red blood cells is an 
adaptation for the high rate of heme 
synthesis required for hemoglobin 
accumulation. Transcriptional and 
post-transcriptional regulatory 
mechanisms ensure that 
mitochondria express high levels 
of Mitoferrin1 at the same time as 
they increase their synthesis of 
porphyrins, the other component of 
heme. Pic1, a four transmembrane 
domain-containing protein localized 
in the chloroplast membrane, 
mediates iron entry. The closest 
homologues to Pic1 are permeases 
in cyanobacteria, perhaps reflecting 
the evolutionary history of 
chloroplasts. 
Regulation of iron distribution 
within eukaryotes
Multicellular organisms need to 
distribute iron from the site of 
absorption to the sites of usage 
or storage. This necessitates 
mechanisms to absorb iron from the 
environment and to export that iron 
from absorptive cells to cells that 
can utilize or store it (Figure 4). In 
vertebrates iron absorption occurs in the upper portion of the intestine 
adjacent to the stomach. Exposure 
to the low pH of the stomach helps 
maintain iron in solution. Intestinal 
cell surface reductases reduce Fe3+ 
to Fe2+, permitting the intestinal 
iron transporter DMT1 to import 
Fe2+. Cytosolic iron is exported 
from the intestine by ferroportin, a 
transporter that is located on the 
basolateral surface of absorptive 
cells. Ferroportin is the only known 
vertebrate iron exporter and is 
found on the surface of all cells that 
export iron, including macrophages, 
hepatocytes and placental mucosa 
cells. Iron exported by ferroportin 
is most probably exported as Fe2+. 
Under physiological conditions iron 
is carried in blood by the iron-binding 
protein transferrin (Tf), which has 
been referred to as the mammalian 
equivalent of siderophores, as its 
affinity for iron is extremely high 
(Kd)10–23 M. Tf is highly selective 
for Fe3+ and can bind two atoms of 
Fe3+ per Tf. Ferroportin-exported 
Fe2+ is rapidly converted to Fe3+ 
by either soluble or membrane-
tethered copper-containing oxidases, 
which can oxidize iron without 
generating oxygen radicals. The 
newly generated Fe3+ rapidly binds 
to the iron-free form of Tf (apoTf). 
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Figure 5. Tf–TfR1-mediated cellular iron uptake.
Tf–Fe binds to the TfR1 on the plasma membrane and is internalized by endocytosis. The pH 
within the endosome drops due to H+ import, allowing Fe3+ to dissociate from Tf. Fe3+ is re-
duced by Steap3 and Fe2+ is transported from endosome to cytosol by DMT1. Iron-free Tf is re-
cycled back to the cell surface where it is released at neutral pH and can rebind plasma Fe3+.Tf(Fe3+) is recognized by specific 
cell-surface Tf receptors (TfRs), 
which bind it with high affinity 
(Figure 5). The Tf(Fe3+)2–TfR complex 
is internalized into an intracellular 
compartment (endosome). This 
compartment has an acidic pH 
resulting from the action of an ATP-
driven H+ pump. The compartment 
also contains a membrane-bound 
reductase (identified in red blood cell 
precursors as Steap3), and the iron 
transporter DMT1. The combination 
of low pH, binding of Tf to the 
TfR and reduction of Fe3+ to Fe2+ 
contribute to the dissociation of iron 
from Tf. Fe2+ can now be transported 
by DMT1 from the endosome to the 
cytosol. ApoTf remains bound to 
the receptor at the low pH of the 
endosome but dissociates from 
the receptor at the neutral pH of 
blood. Released apoTf can now 
bind iron and restart the iron cycle. 
The binding of iron to apoTf ensures 
iron delivery to those cell types 
that need it most. Cells that need 
iron show increased expression of 
TfRs, resulting from transcriptional 
and post-transcriptional regulatory 
mechanisms. 
When the binding capacity of 
apoTf is exceeded by iron entering the blood, non-Tf-bound iron is 
cleared by parenchymal cells, such 
as hepatocytes in the liver. Iron 
stored within hepatocytes can be 
reutilized in times of need. Thus, a 
major problem faced by vertebrates 
is the coordination of iron entry 
into blood with iron utilization and 
storage. Vertebrates have solved 
this problem through the expression 
of the  small peptide hepcidin, 
which is a negative regulator of 
iron acquisition. Hepcidin can be 
synthesized by a number of cell 
types, including hepatocytes and 
macrophages. Hepcidin synthesis 
is increased by iron overload and 
inflammation and is decreased 
by iron demand, erythropoiesis 
and hypoxia. Hepcidin binds to 
ferroportin and induces ferroportin 
internalization and degradation. 
The removal of ferroportin from 
cell surfaces prevents cellular 
iron export, while the absence of 
hepcidin results in increased cell-
surface ferroportin and increased 
iron entry into blood. Mutations that 
affect hepcidin levels may result in 
disease. Increased hepcidin levels 
lead to decreased iron absorption, 
which if persistent will result in the 
production of iron-deficient red blood cells and anemia. Conversely, 
decreased hepcidin levels result in 
increased iron absorption and, if 
prolonged, can lead to iron overload 
disorders. 
Concluding remarks
The dual nature of iron — both its 
essential nature and potentially toxic 
properties — have resulted in the 
evolution of mechanisms to acquire 
iron and to regulate its concentration 
in biological fluids. While there are 
many examples of species-specific 
adaptations to deal with the iron 
conundrum, it is interesting to 
note that many of the transporters 
(DMT1/NRAMP1, Mrs/mitoferrin) 
that evolved to effect iron transfer 
across membranes have been 
conserved throughout evolution. 
Similarly, enzymes that utilize iron or 
synthesize iron-containing molecules 
(Fe–S clusters) have been conserved 
from bacteria to humans. These 
examples of conservation provide 
evidence for the early evolutionary 
development of iron utilization and 
the considerable efforts required to 
safely acquire this element. 
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